McCullough, Craig Schedule 13G/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No.1)*
  
  
Nu Skin Enterprises, Inc.
(Name of Issuer)
  
  
Class A Common Stock
(Title of Class of Securities)
  
  
67018T-10-5
(CUSIP Number)
  
  
December 31, 2001
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed.

[   ]   Rule 13d-1(b)
[   ]   Rule 13d-1(c)
[X]   Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number

SCHEDULE 13G/A (AMENDMENT NO. 1)
CUSIP NO. 6 67018T-10-5

1 NAMES OF REPORTING PERSON(S)
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON(S) (ENTITIES ONLY).
                                                                             Craig F. McCullough

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
                                                                                                                                                      (a)[   ]
                                                                                                                                                      (b)[   ]

3 SEC USE ONLY

4 CITIZENSHIP OR PLACE OF ORGANIZATION
                                                       Craig F. McCullough: United States of America

  
NUMBER OF
5 SOLE VOTING POWER
                                            Craig F. McCullough: 2,400,152**SEE ITEM 4
SHARES

BENEFICIALLY
OWNED BY
6 SHARED VOTING POWER
                                            Craig F. McCullough: 0**SEE ITEM 4
EACH

REPORTING
PERSON WITH
7 SOLE DISPOSITIVE POWER
                                            Craig F. McCullough: 2,400,152**SEE ITEM 4
  

   8 SHARED DISPOSITIVE POWER
                                            Craig F. McCullough: 0**SEE ITEM 4

9 AGGREGATE AMOUNT BENEFICALLY OWNED BY EACH REPORTING
PERSON
                                            Craig F. McCullough: 2,400,152**SEE ITEM 4

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)                                                                            [   ]
    

11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
  
                                            Craig F. McCullough: 6.7%**SEE ITEM 4

12 TYPE OF REPORTING PERSON(S)(SEE INSTRUCTIONS)
  
                                            Craig F. McCullough: IN





Page 2 of 6

SCHEDULE 13G (AMENDMENT NO. 1)
CUSIP NO.67018T-10-5

Item 1 (a) Name of Issuer:
         
       The name of the issuer is Nu Skin Enterprises, Inc. (the "Issuer").
         
   (b) Address of Issuer's Principal Executive Offices:
         
      The address of the Issuer's principal executive office is 75 West Center Street, Provo, Utah 84601.
         
Item 2 (a) Name of Person Filing:
         
      This report is being filed by Craig F. McCullough (the "Reporting Person").
         
   (b) Address of Principal Business Office or, if none, Residence:
         
      The address of the Reporting Person's principal business office is 10 East South Temple Street, Suite 900, Salt Lake City, UT 84133.
         
   (c) Citizenship:
         
      The Reporting Person is a citizen of the United States of America.
         
   (d) Title of Class of Securities:
         
      This report covers the Issuer's Class A Common Stock, par value $.001 per share (the "Class A Common Stock").
         
   (e) CUSIP Number:
         
      The CUSIP number of the Class A Common Stock is 67018T-10-5.
         
Item 3    Not applicable
         
Item 4    Ownership.
         
   (a) The Reporting Person beneficially owns or may be deemed to beneficially own 2,400,152 shares of Class A Common Stock as follows: 152 shares of Class A Common Stock and 2,400,000 shares of the Issuer's Class B Common Stock, par value $.001 per share (the "Class B Common Stock"), which is convertible on a one-for-one basis into Class A Common Stock at any time at the option of the holder. The filing of the above statement shall not be construed as an admission that Craig F. McCullough is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, the beneficial owner of the following shares which were included in




Page 3 of 6

SCHEDULE 13G (AMENDMENT NO. 1)
CUSIP NO.67018T-10-5

      the 2,400,000 shares of Common Stock referenced above: 500,000 shares held indirectly as manager of The B & N Rhino Company, L.C.; 1,500,000 shares held indirectly as manager of The NR Rhino Company, L.C.; 150,000 shares held indirectly as manager of The S & K Rhino Company, L.C.; and 250,000 shares held indirectly as manager of The K & M Rhino Company, L.C.
         
   (b) Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and each share of Class B Common Stock is automatically converted into one share of Class A Common Stock upon the transfer of such share of Class B Common Stock to any person who is not a Permitted Transferee as defined in the Amended and Restated Certificate of Incorporation of the Issuer. Assuming conversion of all outstanding 2,400,000 shares of Class B Common Stock beneficially owned or that may be deemed to be beneficially owned by her, the Reporting Person would beneficially own or may be deemed to beneficially own 2,400,152 shares of Class A Common Stock which would constitute 6.7% of the number of shares of the then outstanding Class A Common Stock.
         
      Each share of Class A Common Stock entitles the holder to one vote on each matter submitted to a vote of the Issuer's Stockholders and each share of Class B Common Stock entitles the holder to ten votes on each such matter, including the election of directors. Assuming conversion of all outstanding 2,400,000 shares of Class B Common Stock beneficially owned or that may be deemed to be beneficially owned by the Reporting Person, he would beneficially own or may be deemed to beneficially own 2,400,152 shares of Class A Common Stock which would constitute 0.5% of the aggregate voting power of the Issuer.
         
      Assuming no conversion of the outstanding 2,400,000 shares of Class B Common Stock beneficially owned or that may be deemed to be beneficially owned by the Reporting Person, hhe would beneficially own or may be deemed to beneficially own 152 shares of Class A Common Stock and 2,400,000 shares of Class B Common Stock which would constitute 4.6% of the aggregate voting power of the Issuer and 2.9% of the total combined number of shares of Class A Common Stock and Class B Common Stock then outstanding.
         
   (c) (i)        Assuming conversion of all outstanding 2,400,000 shares of Class B Common Stock beneficially owned or that may be deemed to be beneficially owned by the Reporting Person, with respect to which he has sole power to vote of direct the vote, the Reporting Person would have sole power to vote or direct the vote of 2,400,152 shares of Class A Common Stock as follows: 152 shares held directly; 500,000 shares held indirectly as manager of The B & N Rhino Company, L.C.; 1,500,000 shares held indirectly as manager of The NR Rhino Company, L.C.; 150,000 shares held indirectly as manager of The S & K Rhino Company, L.C.; and 250,000 shares held indirectly as manager of The K & M Rhino Company, L.C.
         
      (ii)        Not applicable.




Page 4 of 6

SCHEDULE 13G (AMENDMENT NO. 1)
CUSIP NO.67018T-10-5

       (iii)         Assuming conversion of all outstanding 2,400,000 shares of Class B Common Stock beneficially owned or that may be deemed to be beneficially owned by the Reporting Person, with respect to which he has sole power to dispose of direct the disposition, the Reporting Person would have sole power to dispose or direct the disposition of 2,400,152 shares of Class A Common Stock as follows: 152 shares held directly; 500,000 shares held indirectly as manager of The B & N Rhino Company, L.C.; 1,500,000 shares held indirectly as manager of The NR Rhino Company, L.C.; 150,000 shares held indirectly as manager of The S & K Rhino Company, L.C.; and 250,000 shares held indirectly as manager of The K & M Rhino Company, L.C.
         
       (iv)         Not Applicable.
         
Item 5     Ownership of Five Percent of Less of a Class.
         
       Not applicable.
         
Item 6     Ownership of More than Five Percent on Behalf of Another Person.
         
       Not applicable.
         
Item 7     Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
         
       Not applicable.
         
Item 8     Identification and Classification of Members of the Group.
         
       Not applicable.
         
Item 9     Notice of Dissolution of Group.
         
       Not applicable.
         
Item 10     Certification.
         
       Not applicable.




Page 5 of 6

SCHEDULE 13G (AMENDMENT NO. 1)
CUSIP NO.67018T-10-5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.





   /S/ Craig F. McCullough                  
   By:   Craig F. McCullough
   Dated:   February 14, 2002










Page 6 of 6